• OPEN AN ACCOUNT
Indian Indices
Sensex
78,542.44 43.27
( 0.06%)
Global Indices
Nasdaq
54,056.75 150.65
(0.28%)
Dow Jones
7,778.11 47.15
(0.61%)
Hang Seng
66,870.65 1,263.94
(1.93%)
Nikkei 225
10,909.12 41.23
(0.38%)
Forex
USD-INR
95.20 0.13
(0.14%)
EUR-INR
109.83 0.08
(0.08%)
GBP-INR
128.13 0.14
(0.11%)
JPY-INR
0.60 0.00
(-0.12%)

EQUITY - MARKET SCREENER

Om Infra Ltd
Industry :  Engineering - Turnkey Services
BSE Code
ISIN Demat
Book Value()
531092
INE239D01028
82.513909
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
OMINFRAL
38.74
843.24
EPS(TTM)
Face Value()
Div & Yield %
2.26
1
0.57
 

cress&a solutions ltd
InvaGen receives EIR report for its facility in Hauppauge, New York
Aug 04,2026
Cipla announced that its wholly owned subsidiary, InvaGen Pharmaceuticals (InvaGen) has received the Establishment Inspection Report (EIR) from the USFDA, indicating the closure of the inspection of its manufacturing facility located at Hauppauge, Long Island, New York, USA.